QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
Log in
NASDAQ:AUTL

Autolus Therapeutics News Headlines

$10.58
+0.45 (+4.44 %)
(As of 11/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$9.92
Now: $10.58▼
$10.60
50-Day Range
$10.13
MA: $11.48▼
$12.79
52-Week Range
$3.00
Now: $10.58▼
$17.19
Volume103,857 shs
Average Volume155,912 shs
Market Capitalization$475.92 million
P/E RatioN/A
Dividend YieldN/A
Beta2.02

Headlines

Autolus Therapeutics (NASDAQ AUTL) News Headlines Today

Source:
SourceHeadline
Redburn Partners Initiates Coverage on Autolus Therapeutics (NASDAQ:AUTL)Redburn Partners Initiates Coverage on Autolus Therapeutics (NASDAQ:AUTL)
marketbeat.com - November 25 at 9:45 AM
Autolus Therapeutics (NASDAQ:AUTL) Downgraded to Strong Sell at BidaskClubAutolus Therapeutics (NASDAQ:AUTL) Downgraded to Strong Sell at BidaskClub
marketbeat.com - October 22 at 2:31 AM
BidaskClub Lowers Autolus Therapeutics (NASDAQ:AUTL) to SellBidaskClub Lowers Autolus Therapeutics (NASDAQ:AUTL) to Sell
marketbeat.com - September 29 at 10:15 AM
Autolus Therapeutics (NASDAQ:AUTL) Earns "Buy" Rating from MizuhoAutolus Therapeutics (NASDAQ:AUTL) Earns "Buy" Rating from Mizuho
marketbeat.com - August 6 at 3:47 PM
Eli Lilly (NYSE:LLY) Readies New Coronavirus Drug for Testing in Nursing Homes (AUTL)Eli Lilly (NYSE:LLY) Readies New Coronavirus Drug for Testing in Nursing Homes (AUTL)
marketbeat.com - August 3 at 2:09 PM
Autolus Therapeutics (NASDAQ:AUTL) Coverage Initiated by Analysts at Redburn PartnersAutolus Therapeutics (NASDAQ:AUTL) Coverage Initiated by Analysts at Redburn Partners
americanbankingnews.com - November 25 at 11:03 AM
Autolus Therapeutics plc (NASDAQ:AUTL) Short Interest Up 12.9% in OctoberAutolus Therapeutics plc (NASDAQ:AUTL) Short Interest Up 12.9% in October
americanbankingnews.com - November 22 at 2:06 AM
Autolus Therapeutics to host Investor Conference Call to discuss AUTO1 and AUTO3 data presented at ASH and to participate in the Jefferies Virtual London Healthcare ConferenceAutolus Therapeutics to host Investor Conference Call to discuss AUTO1 and AUTO3 data presented at ASH and to participate in the Jefferies Virtual London Healthcare Conference
finance.yahoo.com - November 17 at 9:58 AM
Autolus Therapeutics plc (NASDAQ:AUTL) Receives Consensus Rating of "Buy" from AnalystsAutolus Therapeutics plc (NASDAQ:AUTL) Receives Consensus Rating of "Buy" from Analysts
americanbankingnews.com - November 15 at 3:42 AM
Autolus Therapeutics (NASDAQ:AUTL) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPSAutolus Therapeutics (NASDAQ:AUTL) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS
americanbankingnews.com - November 10 at 1:35 PM
Earnings Beat: Autolus Therapeutics plc (NASDAQ:AUTL) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their ForecastsEarnings Beat: Autolus Therapeutics plc (NASDAQ:AUTL) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
finance.yahoo.com - November 7 at 11:59 AM
News Flash: Analysts Just Made A Meaningful Upgrade To Their Autolus Therapeutics plc (NASDAQ:AUTL) ForecastsNews Flash: Analysts Just Made A Meaningful Upgrade To Their Autolus Therapeutics plc (NASDAQ:AUTL) Forecasts
finance.yahoo.com - November 6 at 7:47 AM
Autolus Therapeutics Reports Third Quarter 2020 Financial Results and Operational ProgressAutolus Therapeutics Reports Third Quarter 2020 Financial Results and Operational Progress
finance.yahoo.com - November 5 at 9:54 AM
Autolus Therapeutics (AUTL) Set to Announce Quarterly Earnings on ThursdayAutolus Therapeutics (AUTL) Set to Announce Quarterly Earnings on Thursday
americanbankingnews.com - October 31 at 10:21 AM
Autolus Therapeutics to Report Third Quarter 2020 Financial Results and Host Conference Call on November 5Autolus Therapeutics to Report Third Quarter 2020 Financial Results and Host Conference Call on November 5
finance.yahoo.com - October 30 at 11:56 AM
Autolus AUTO3 shows promising results in blood cancer studyAutolus' AUTO3 shows promising results in blood cancer study
seekingalpha.com - September 18 at 12:32 PM
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during ESMO eventAutolus Therapeutics presents additional data on AUTO3 in DLBCL during ESMO event
seekingalpha.com - September 18 at 7:31 AM
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO Virtual Congress 2020Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO Virtual Congress 2020
finance.yahoo.com - September 18 at 7:31 AM
Week Ahead In Pharma: FDA Decisions, Data Readouts, ESMO PresentationsWeek Ahead In Pharma: FDA Decisions, Data Readouts, ESMO Presentations
nasdaq.com - September 13 at 7:09 AM
Autolus Therapeutics to host Investor Conference Call to discuss AUTO3 data presented at ESMO and to participate in Banking conferences through SeptemberAutolus Therapeutics to host Investor Conference Call to discuss AUTO3 data presented at ESMO and to participate in Banking conferences through September
finance.yahoo.com - September 8 at 7:25 AM
Can You Imagine How Autolus Therapeutics (NASDAQ:AUTL) Shareholders Feel About The 47% Share Price Increase?Can You Imagine How Autolus Therapeutics' (NASDAQ:AUTL) Shareholders Feel About The 47% Share Price Increase?
finance.yahoo.com - September 1 at 8:06 AM
Can You Imagine How Autolus Therapeutics' (NASDAQ:AUTL) Shareholders Feel About The 47% Share Price Increase?Can You Imagine How Autolus Therapeutics' (NASDAQ:AUTL) Shareholders Feel About The 47% Share Price Increase?
finance.yahoo.com - September 1 at 8:06 AM
Autolus Therapeutics PLC (AUTL) CEO Christian Itin on Q2 2020 Results - Earnings Call TranscriptAutolus Therapeutics PLC (AUTL) CEO Christian Itin on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 8:21 AM
Autolus Therapeutics EPS beats by $0.10, misses on revenueAutolus Therapeutics EPS beats by $0.10, misses on revenue
seekingalpha.com - August 6 at 7:43 AM
Autolus Therapeutics Reports Second Quarter 2020 Financial Results and Operational ProgressAutolus Therapeutics Reports Second Quarter 2020 Financial Results and Operational Progress
finance.yahoo.com - August 6 at 7:43 AM
Autolus Therapeutics to Report Second Quarter 2020 Financial Results and Host Conference Call on August 6Autolus Therapeutics to Report Second Quarter 2020 Financial Results and Host Conference Call on August 6
finance.yahoo.com - July 30 at 8:25 AM
Why Autolus Therapeutics Is Trading Higher TodayWhy Autolus Therapeutics Is Trading Higher Today
www.benzinga.com - July 22 at 12:27 PM
Hedge Funds Are Buying Autolus Therapeutics plc (AUTL)Hedge Funds Are Buying Autolus Therapeutics plc (AUTL)
finance.yahoo.com - July 2 at 7:56 PM
Moving Average Crossover Alert: Autolus TherapeuticsMoving Average Crossover Alert: Autolus Therapeutics
finance.yahoo.com - June 24 at 2:19 PM
Autolus Therapeutics presents new preclinical data during the Virtual 2020 AACR Annual MeetingAutolus Therapeutics presents new preclinical data during the Virtual 2020 AACR Annual Meeting
finance.yahoo.com - June 22 at 8:52 AM
Is Autolus Therapeutics PLC Sponsored (AUTL) Stock Outpacing Its Medical Peers This Year?Is Autolus Therapeutics PLC Sponsored (AUTL) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - June 19 at 3:05 PM
Arix Bioscience Plc - Autolus AUTO1 and AUTO3 data at EHAArix Bioscience Plc - Autolus AUTO1 and AUTO3 data at EHA
uk.finance.yahoo.com - June 12 at 8:13 AM
Autolus Therapeutics presents AUTO1 and AUTO3 data at the 2020 EHA25 Virtual CongressAutolus Therapeutics presents AUTO1 and AUTO3 data at the 2020 EHA25 Virtual Congress
finance.yahoo.com - June 12 at 8:13 AM
Autolus Therapeutics reschedules its investor EHA conference callAutolus Therapeutics reschedules its investor EHA conference call
finance.yahoo.com - June 8 at 6:46 PM
Industry Analysts Just Upgraded Their Autolus Therapeutics plc (NASDAQ:AUTL) Revenue Forecasts By -3.3%Industry Analysts Just Upgraded Their Autolus Therapeutics plc (NASDAQ:AUTL) Revenue Forecasts By -3.3%
finance.yahoo.com - June 3 at 8:30 AM
Autolus Therapeutics Shares March Higher, Can It Continue?Autolus Therapeutics' Shares March Higher, Can It Continue?
finance.yahoo.com - June 2 at 9:19 AM
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ASCO20 Virtual Scientific ProgramAutolus Therapeutics presents additional data on AUTO3 in DLBCL during the ASCO20 Virtual Scientific Program
finance.yahoo.com - May 29 at 9:14 AM
Autolus Therapeutics to host Investor Conference Calls through JuneAutolus Therapeutics to host Investor Conference Calls through June
finance.yahoo.com - May 26 at 8:47 AM
Autolus Therapeutics to Present New Data at the Virtual 2020 AACR Annual MeetingAutolus Therapeutics to Present New Data at the Virtual 2020 AACR Annual Meeting
finance.yahoo.com - May 15 at 3:07 PM
Autolus Therapeutics to Present New Data on AUTO1 and AUTO3 at the 2020 EHA Annual MeetingAutolus Therapeutics to Present New Data on AUTO1 and AUTO3 at the 2020 EHA Annual Meeting
finance.yahoo.com - May 15 at 10:05 AM
Autolus Therapeutics to Present New Data on AUTO3 during the ASCO20 Virtual Scientific ProgramAutolus Therapeutics to Present New Data on AUTO3 during the ASCO20 Virtual Scientific Program
finance.yahoo.com - May 14 at 8:21 AM
Is Autolus Therapeutics (AUTL) Stock a Solid Choice Right Now?Is Autolus Therapeutics (AUTL) Stock a Solid Choice Right Now?
finance.yahoo.com - May 13 at 10:22 AM
Will Autolus Therapeutics Continue to Surge Higher?Will Autolus Therapeutics Continue to Surge Higher?
finance.yahoo.com - May 12 at 6:14 PM
Autolus Therapeutics PLC Sponsored ADR (AUTL) Upgraded to Strong Buy: What Does It Mean for the Stock?Autolus Therapeutics PLC Sponsored ADR (AUTL) Upgraded to Strong Buy: What Does It Mean for the Stock?
finance.yahoo.com - May 12 at 6:14 PM
Autolus Therapeutics Plc (AUTL) CEO Christian Itin on Q1 2020 Results - Earnings Call TranscriptAutolus Therapeutics Plc (AUTL) CEO Christian Itin on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 12:44 PM
Analyst Estimates: Heres What Brokers Think Of Autolus Therapeutics plc (NASDAQ:AUTL) After Its First-Quarter ReportAnalyst Estimates: Here's What Brokers Think Of Autolus Therapeutics plc (NASDAQ:AUTL) After Its First-Quarter Report
finance.yahoo.com - May 10 at 12:44 PM
Analyst Estimates: Here's What Brokers Think Of Autolus Therapeutics plc (NASDAQ:AUTL) After Its First-Quarter ReportAnalyst Estimates: Here's What Brokers Think Of Autolus Therapeutics plc (NASDAQ:AUTL) After Its First-Quarter Report
finance.yahoo.com - May 10 at 12:44 PM
Is Autolus Therapeutics (NASDAQ:AUTL) In A Good Position To Deliver On Growth Plans?Is Autolus Therapeutics (NASDAQ:AUTL) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - May 9 at 9:40 AM
Autolus Therapeutics: Q1 Earnings InsightsAutolus Therapeutics: Q1 Earnings Insights
finance.yahoo.com - May 7 at 12:23 PM
Autolus Therapeutics Reports First Quarter 2020 Financial Results and Operational ProgressAutolus Therapeutics Reports First Quarter 2020 Financial Results and Operational Progress
finance.yahoo.com - May 7 at 7:22 AM
Autolus Therapeutics to Report First Quarter 2020 Financial Results and Host Conference Call on May 7Autolus Therapeutics to Report First Quarter 2020 Financial Results and Host Conference Call on May 7
finance.yahoo.com - May 1 at 10:06 AM
Autolus on go to start U.S. studies of CAR T candidate for ALLAutolus on go to start U.S. studies of CAR T candidate for ALL
seekingalpha.com - April 16 at 1:04 PM
Autolus Therapeutics Announces FDA Acceptance of IND Application for AUTO1 for Adult Acute Lymphoblastic LeukemiaAutolus Therapeutics Announces FDA Acceptance of IND Application for AUTO1 for Adult Acute Lymphoblastic Leukemia
finance.yahoo.com - April 16 at 8:03 AM
BRIEF-Molmed Signs Agreement With Autolus TherapeuticsBRIEF-Molmed Signs Agreement With Autolus Therapeutics
www.reuters.com - March 6 at 8:53 AM
Autolus Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Operational ProgressAutolus Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Progress
finance.yahoo.com - March 3 at 8:18 AM
This page was last updated on 11/25/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.